Erythropoietin (EPO) is the main hematopoietic hormone acting on progenitor red blood cells via stimulation of cell growth, differentiation, and anti-apoptosis. However, its receptor (EPOR) is also expressed in various non-hematopoietic tissues, including endothelium. EPO is a pleiotropic growth factor that exhibits growth stimulation and cell/tissue protection on numerous cells and tissues. In this article we review the angiogenesis potential of EPO on endothelial cells in heart, brain, and leg ischemia, as well as its role in retinopathy protection and tumor promotion. Furthermore, the effect of EPO on bone marrow and adipose tissue is also discussed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536009 | PMC |
| http://dx.doi.org/10.3390/ijms18071519 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bioactive hydrogel synergizes neuroprotection, macrophage polarization, and angiogenesis to improve repair of traumatic brain injury.
Mater Today Bio
December 2024
Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China.
Article Synopsis
- Traumatic brain injury (TBI) can result in serious cognitive decline and even death due to massive neuronal loss and neuroinflammation; a novel hydrogel was developed to address these issues.
- The hydrogel, called GC/I/E, incorporates Erythropoietin for rapid neuroprotection and angiogenesis, along with Mesoporous silica nanoparticles loaded with Interleukin-4 for sustained inflammation modulation.
- Experiments show that GC/I/E is biocompatible, reduces brain edema, improves vascular function, and enhances neuronal recovery, indicating its promising potential for treating TBI.
EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation.
Signal Transduct Target Ther
November 2024
Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institute of Biomedical Sciences, Fudan University, Shanghai, China.
Article Synopsis
- EphrinB2 is crucial for promoting the formation of blood and lymph vessels during embryo development and plays a significant role in cardiac lymphangiogenesis after a heart attack (myocardial infarction, MI).
- The study found that EphrinB2 helps prevent heart remodeling and dysfunction post-MI by activating pathways involved in lymphangiogenesis, with its absence leading to worsening heart conditions.
- Mechanistically, EphrinB2 enhances the proliferation and migration of lymphatic endothelial cells, boosts the activity of a specific transcription factor (ISL1), and its effects are diminished when the VEGFR3 pathway is inhibited, highlighting its importance in cardiac recovery after MI.
Enduring effects of acute prenatal ischemia in rat soleus muscle, and protective role of erythropoietin.
J Muscle Res Cell Motil
November 2024
Univ. Lille, Univ Artois, Univ Littoral Côte d'Opale, URePSSS - Unité de Recherche Pluridisciplinaire Sport Santé Société, ULR7369, Lille, F-59000, France.
Motor disorders are considered to originate mainly from brain lesions. Placental dysfunction or maternal exposure to a persistently hypoxic environment is a major cause of further motor disorders such as cerebral palsy. Our main goal was to determine the long-term effects of mild intrauterine acute ischemic stress on rat soleus myofibres and whether erythropoietin treatment could prevent these changes.
View Article and Find Full Text PDFImmunohistochemical expression of ephrin receptors in neuroendocrine neoplasms: a case-series of gastroenteropancreatic neuroendocrine neoplasms and a systematic review of the literature.
Endocrine
October 2024
Endocrine Unit, First Department of Propaedeutic Medicine, Laiko University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Article Synopsis
- The study investigates the expression of Erythropoietin-producing hepatocellular (EPH) receptors in neuroendocrine neoplasms (NENs), which are significant in various biological processes including tumor growth and spread.
- Immunohistochemical analysis of tumor samples from 30 patients showed varying levels of expression for different EPH subtypes, with high positivity rates for EPH-A4 and EPH-A5.
- The findings suggest that EPH receptors could play a crucial role in the development and treatment of NENs, highlighting their potential as targets for new therapeutic strategies.
Chronic Administration of Recombinant Human Erythropoietin Induces Angiogenesis in Healthy Mouse Brain.
Cureus
September 2024
Histology-Embryology, Democritus University of Thrace, Alexandroupolis, GRC.
Article Synopsis
- Erythropoietin (EPO) is a key growth factor that helps reduce cell death, manage oxidative stress, and promote new blood vessel formation (angiogenesis) in various tissues.
- In a study using BALB/c mice, researchers compared the effects of EPO treatment versus no treatment and saline injection on brain angiogenesis.
- The results showed that chronic treatment with recombinant human erythropoietin (rHuEPO) significantly increased the number of blood vessels in healthy mouse brains by 44%, indicating that lesions or low oxygen levels are not required for EPO's angiogenic effects.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!